My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    1.

    Screening for cervical cancer.

    Eddy DM.

    Ann Intern Med. 1990 Aug 1;113(3):214-26. Review.PMID: 2115753 [PubMed - indexed for MEDLINE]Related articles

    2.

    Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.

    Macgregor JE, Campbell MK, Mann EM, Swanson KY.

    BMJ. 1994 May 28;308(6941):1407-11.PMID: 8019250 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.

    Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E.

    J Natl Cancer Inst. 2004 Apr 21;96(8):604-15.PMID: 15100338 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on the incidence of invasive cervical cancer.

    Helfand M, O'Connor GT, Zimmer-Gembeck M, Beck JR.

    Med Care. 1992 Dec;30(12):1067-82.PMID: 1453813 [PubMed - indexed for MEDLINE]Related articles

    5.

    Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

    Kulasingam SL, Myers ER.

    JAMA. 2003 Aug 13;290(6):781-9.PMID: 12915431 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cost-effectiveness of cervical cancer screening: comparison of screening policies.

    van den Akker-van Marle ME, van Ballegooijen M, van Oortmarssen GJ, Boer R, Habbema JD.

    J Natl Cancer Inst. 2002 Feb 6;94(3):193-204.PMID: 11830609 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.

    Hutchinson ML, Berger BM, Farber FL.

    Am J Manag Care. 2000 Jul;6(7):766-80.PMID: 11067374 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [Cost effectiveness of cervical cancer screening strategies in Tunisia]

    Hsaïri M, Fakhfakh R, Ghyoula M, Ben Abdallah M, Achour N.

    Tunis Med. 2000 Oct;78(10):557-61. French. PMID: 11190738 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cost-effective policies for cervical cancer screening. An international review.

    Fahs MC, Plichta SB, Mandelblatt JS.

    Pharmacoeconomics. 1996 Mar;9(3):211-30. Review.PMID: 10160098 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.

    Taylor LA, Sorensen SV, Ray NF, Halpern MT, Harper DM.

    Arch Fam Med. 2000 Aug;9(8):713-21.PMID: 10927709 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Papanicolaou cervical smears for screening in asymptomatic women.

    Barnes BA.

    Prim Care. 1981 Mar;8(1):131-40.PMID: 6911755 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cost-effectiveness of screening for colorectal cancer in the general population.

    Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

    JAMA. 2000 Oct 18;284(15):1954-61.PMID: 11035892 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.

    Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.

    J Natl Cancer Inst. 2002 Oct 2;94(19):1469-83.PMID: 12359856 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Benefits and costs of using HPV testing to screen for cervical cancer.

    Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K.

    JAMA. 2002 May 8;287(18):2372-81.PMID: 11988058 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.

    Kim JJ, Leung GM, Woo PP, Goldie SJ.

    J Public Health (Oxf). 2004 Jun;26(2):130-7.PMID: 15284314 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.

    Kim JJ, Wright TC, Goldie SJ.

    JAMA. 2002 May 8;287(18):2382-90.PMID: 11988059 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Assessment of cervical cancer screening and follow-up programs.

    Celentano DD, deLissovoy G.

    Public Health Rev. 1989-1990;17(2-3):173-240. Review.PMID: 2518819 [PubMed - indexed for MEDLINE]Related articles

    18.

    What is the most cost-effective population-based cancer screening program for Chinese women?

    Woo PP, Kim JJ, Leung GM.

    J Clin Oncol. 2007 Feb 20;25(6):617-24.PMID: 17308266 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.

    Brown AD, Garber AM.

    JAMA. 1999 Jan 27;281(4):347-53.PMID: 9929088 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.

    Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, Yood MU, Gilbert J, Taplin SH.

    J Natl Cancer Inst. 2005 May 4;97(9):675-83.PMID: 15870438 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity